F.X. v The Clinical Director of Central Mental Hospital and Another

NEW YORK CENTER FOR LIVING (NYCFL) ANNOUNCES EXPANSION OF CLINICAL SERVICES

Retrieved on: 
Thursday, September 28, 2023
LCSW, Employment, Education, New York University Silver School of Social Work, NYU, Quality management, Mental health, Lead, Union Settlement, Silver, Substance, Social work, School, Health care, Dialectical behavior therapy, Hostos Community College, Simula Metropolitan Center for Digital Engineering, Callen-Lorde Community Health Center, Health, F.X. v The Clinical Director of Central Mental Hospital and Another, Nursing

NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Responding to the increasing demand for quality programs, information, and education surrounding substance use disorders and sustainable sober living, NYCFL, an outpatient program serving adolescents, emerging adults, and families with substance use and co-occurring disorders, has expanded clinical programs and are now providing high fidelity Dialectical Behavior Therapy for Substance Use.

Key Points: 
  • Darwin Abreu, LCSW-R, joins the Center as the Clinical Director and will be responsible for leading the team of clinicians who provide comprehensive, evidence-based care while supporting 12-step and related recovery programs.
  • Prior to that, he held both direct practice and management positions at Union Settlement Association, Callen-Lorde Community Health Center, Casita Maria, and Beth-Abraham, Health Services.
  • Located in New York City, NYCFL is a private not-for-profit outpatient treatment center that was established in 2007.
  • For more information on the New York Center for Living visit: www.centerforliving.org

BlazerWorks Announces Formation of Mission-Critical Special Education Advisory Team

Retrieved on: 
Wednesday, January 11, 2023
Education, Occupational therapy, Central Florida, Exceptional Children, School, Special education, Achievement Medal, Council, Seton Hall University, Administrator, Research, Job, M.A, COVID-19, Santa Fe Public Schools, University, Portland State University, CPI, OTR/L, Private practice, Augmentative and alternative communication, Washington University in St. Louis, Pathology, K-12, Person-centered therapy, Love, Student, LEP, McCormack, Wilmington University, F.X. v The Clinical Director of Central Mental Hospital and Another, Professional, Azusa Pacific University, Management, Medicine

ATLANTA, Jan. 11, 2023 /PRNewswire-PRWeb/ -- BlazerWorks, the leading K-12 managed service provider, today announced the formation of its new strategic Special Education Clinical Advisory Team. Members of the advisory team will help guide the company's vision and mission-critical work to support school districts in driving success, improving outcomes, and transforming the future of special education.

Key Points: 
  • ATLANTA, Jan. 11, 2023 /PRNewswire-PRWeb/ -- BlazerWorks , the leading K-12 managed service provider, today announced the formation of its new strategic Special Education Clinical Advisory Team.
  • With the Clinical Special Education Advisory Team, BlazerWorks supports districts and school-based professionals by providing special education advisory services to fully integrate clinical expertise into learning environments, enrich therapists and teachers, enhance school staff and staffing programs, and elevate the educational experience.
  • The Special Education Clinical Advisory Team consists of Special Education Teachers, School Psychologists, Speech-Language Pathologists, Occupational Therapists, and other special education disciplines.
  • BlazerWorks Clinical Special Education Advisory Team offers clinical expertise and insights and perspectives for schools and education professionals.

Dr. Zhi Meng Promoted to Chief Clinical Operations Officer

Retrieved on: 
Wednesday, December 28, 2022
Health, Dental, Practice Management, Other Health, Region, Research, Health, Patient, F.X. v The Clinical Director of Central Mental Hospital and Another, David Geffen School of Medicine at UCLA, Medical device, Dentistry, Western Dental

Sonrava Health, a national family of health and wellness companies, today announced that Dr. Zhi Meng has been promoted to Chief Clinical Operations Officer.

Key Points: 
  • Sonrava Health, a national family of health and wellness companies, today announced that Dr. Zhi Meng has been promoted to Chief Clinical Operations Officer.
  • Reporting to Chief of Staff Greg Marotta, Dr. Meng has overall operational responsibility for more than 560 Sonrava Health dental offices nationwide.
  • While continuing to lead the West region directly, the leaders of the East and Central regions now report to her, as well as national clinical recruiting.
  • She was a practicing dentist for 12 years before taking a leadership role in operations as a Clinical Director.

Professional Physical Therapy Celebrates Successful and Growing Clinical Affiliation Program

Retrieved on: 
Tuesday, September 6, 2022
University, Program, College, List of halls and walks of fame, Physical therapy, Education, CAP, Student, Multimedia, Partner, Professional, F.X. v The Clinical Director of Central Mental Hospital and Another, APTA, Mercy College, Growth, American Physical Therapy Association, Contract, Patient, Medicine

MELVILLE, N.Y., Sept. 6, 2022 /PRNewswire/ -- Professional Physical Therapy, a leading provider of outpatient physical therapy and rehabilitation services in the Northeast, is proud to celebrate the recognition of their Clinical Affiliation Program. Now expanded to over 100 College and University partners, the program offers undergraduate students the opportunity to gain hands-on experience and receive mentorship with Professional's renowned clinical instructors.

Key Points: 
  • MELVILLE, N.Y., Sept. 6, 2022 /PRNewswire/ -- Professional Physical Therapy, a leading provider of outpatient physical therapy and rehabilitation services in the Northeast, is proud to celebrate the recognition of their Clinical Affiliation Program.
  • On July 21, 2022, Mercy College awarded Professional with the prestigious Hall of Fame award for exceptional clinical education for Physical Therapy.
  • For more information about participating in a clinical affiliation with Professional Physical Therapy, contactProfessional at [email protected] or click here to learn more about the program.
  • Professional's Clinical Affiliation Program offers students an opportunity to gain hands-on experience with our patients and receive mentorship with our clinical instructors.

CDR-Life Announces Appointment of Swethajit Biswas, MD, as Chief Medical Officer

Retrieved on: 
Tuesday, August 23, 2022
Partnership, University, Royal college, Cancer, F.X. v The Clinical Director of Central Mental Hospital and Another, FRCP, National Health Service, Time, Doctor of Philosophy, Multiple myeloma, Severe cognitive impairment, GSK, Royal College of Physicians, Geographic atrophy, LinkedIn, Newcastle, MHC, Antigen, NHS, BCMA, GlaxoSmithKline, Brain, GLOBE, Company, Biotechnology, Therapy, Twitter, Boehringer Ingelheim, Cancer/testis antigens, Sarcoma, Oncology, TCR, Patient, Lymphoma, Fine chemical, Pharmaceutical industry, MD

Prior to joining CDR-Life, Dr. Biswas was a Development Leader for MAGE-A4+ autologous cell therapies at Adaptimmune Therapeutics plc, progressing afamitresgene autoleucel through an accelerated approval submission pathway.

Key Points: 
  • Prior to joining CDR-Life, Dr. Biswas was a Development Leader for MAGE-A4+ autologous cell therapies at Adaptimmune Therapeutics plc, progressing afamitresgene autoleucel through an accelerated approval submission pathway.
  • He also held an academic position as a Clinical Senior Lecturer in medical oncology at Newcastle Universitys Northern Institute for Cancer Research (NICR) from 2009 to 2013.
  • Dr. Biswas received his medical degree from Sheffield University Medical School and his DPhil from the University of Oxford.
  • For more information, please visit cdr-life.com and follow the Company on Twitter and LinkedIn.

Turning Point of Tampa Is Celebrating 35 Years of Providing the Tampa Community With the Highest Quality Addiction Treatment

Retrieved on: 
Thursday, February 3, 2022
National Association, CEO, Substance abuse, Lists of diseases, F.X. v The Clinical Director of Central Mental Hospital and Another, Addiction, Eating disorder, Woman, GLOBE, Man, Medicine, Pharmaceutical industry

Tampa, FL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Turning Point of Tampa will celebrate 35 years of serving clients suffering from addiction , substance abuse and eating disorders.

Key Points: 
  • Tampa, FL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Turning Point of Tampa will celebrate 35 years of serving clients suffering from addiction , substance abuse and eating disorders.
  • Turning Point of Tampa is set apart from other treatment centers by working as educators in the field, providing resources and educational opportunities for our community partners.
  • Turning Point of Tampa acknowledges all healthcare workers committed to those suffering from addiction and on their journey to recovery.
  • For more information on Turning Point of Tampa or to hear more about our programs for addiction , substance abuse or an eating disorder, please contact us.

Mitotech to Host Key Opinion Leader Webinar on Visomitin®: A Potential Treatment for Dry Eye Disease

Retrieved on: 
Thursday, January 27, 2022
Solution, University of Pikeville Kentucky College of Osteopathic Medicine, Board, Ophthalmology, Medical director, Visual inspection, DED, University, Q&A, Senior, Inflammation, University of Kentucky College of Medicine, Ora, Duane syndrome, Apoptosis, LHON, Glaucoma, F.X. v The Clinical Director of Central Mental Hospital and Another, Center, Internet, Oxidative stress, Gettysburg College, Lists of people executed in the United States, Patient, VISTA, Mitochondrion, KOL, GLOBE, Associate, Pharmaceutical industry, Management, Optometry, Optometry, Indiana University

LUXEMBOURG, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Mitotech, a clinical stage biotechnology company focused on the development of novel small-molecule therapies for the treatment of a range of ophthalmic indications, today announced that it will host a key opinion leader (KOL) webinar on Visomitin and its potential for the treatment of dry eye disease, on Friday, February 4, 2022 at 8:00 AM EST (14.00 CET).

Key Points: 
  • The event will feature presentations from Key Opinion Leaders (KOLs) John D. Sheppard, M.D., M.M.Sc.
  • (Clinical Director of Advanced Ocular Surface Disease at Kentucky Eye Institute), and George W. Ousler III (Senior Vice President of Dry Eye at Ora, Inc) who will discuss the current treatment landscape and unmet medical need in treating patients with dry eye disease.
  • He is committed to providing the highest quality eye care solutions and is widely regarded as a leader in his field.
  • Visomitin is a cardiolipin peroxidation inhibitor, under development for multiple indications including LHON, dry eye disease (DED) and glaucoma.